What should be included in the criteria for compulsive sexual behavior disorder?
What should be included in the criteria for compulsive sexual behavior disorder?
复制标题
DOI：
10.1556/2006.2020.00090
复制
发表时间：
2020-11-25
影响因子：
7.8
通讯作者：
REID, R. O. R. Y. C.
中科院分区：
文献类型：
--
作者：
GOLA, M. A. T. E. U. S. Z.;LEWCZUK, K. A. R. O. L.;POTENZA, M. A. R. C. N.;KINGSTON, D. R. E. W. A.;GRUBBS, J. O. S. H. U. A. B.;STARK, R. U. D. O. L. F.;REID, R. O. R. Y. C.
强迫性行为障碍（CSBD）目前在国际疾病分类（ICD-11）第十一次修订版中被定义为冲动控制障碍。2010年《诊断与统计手册》第五版提出了性功能亢进的诊断标准。在这篇文章中，我们比较了HD和CSBD之间的差异，并讨论了它们的相关性。HD与CSBD标准之间的显著差异包括：（1）性行为作为一种适应不良的应对和情绪调节策略的作用在HD标准中被列出，而在CSBD标准中没有;（2）不同的排除标准，包括HD中的双相情感障碍和物质使用障碍，但不包括CSBD，以及（3）在CSBD中纳入新的考虑因素，例如道德不一致（作为排除标准），和减少性活动的乐趣。这些方面都有临床和研究相关的影响。将CSBD纳入ICD-11将对临床实践和研究产生重大影响。研究人员应继续研究CSBD的核心和相关特征，包括那些未包括在当前标准中的特征，以提供对该疾病的额外见解并帮助促进临床进展。
Compulsive sexual behavior disorder (CSBD) is currently defined in the eleventh revision of the International Classification of Diseases (ICD-11) as an impulse control disorder. Criteria for hypersexual disorder (HD) had been proposed in 2010 for the fifth revision of Diagnostic and Statistical Manual (DSM-5). In this article, we compare differences between HD and CSBD and discuss their relevance. Significant differences between HD and CSBD criteria include: (1) the role of sexual behavior as a maladaptive coping and emotion regulation strategy listed in criteria for HD but not in those for CSBD; (2) different exclusionary criteria including bipolar and substance use disorders in HD but not in CSBD, and (3) inclusion of new considerations in CSBD, such as moral incongruence (as an exclusion criterion), and diminished pleasure from sexual activity. Each of these aspects has clinical and research-related implications. The inclusion of CSBD in the ICD-11 will have a significant impact on clinical practice and research. Researchers should continue to investigate core and related features of CSBD, inlcuding those not included in the current criteria, in order to provide additional insight into the disorder and to help promote clinical advances.
登录
查看更多内容
影响因子：
7.8
作者：
Gola, Mateusz;Potenza, Marc N.
通讯作者：
Potenza, Marc N.
影响因子：
3.8
作者：
Kafka, Martin P.
通讯作者：
Kafka, Martin P.
影响因子：
4.4
作者：
Chen, Lijun;Luo, Xiaohui;Potenza, Marc N.
通讯作者：
Potenza, Marc N.
影响因子：
2.2
作者：
Bridges, Ana J.;Wosnitzer, Robert;Liberman, Rachael
通讯作者：
Liberman, Rachael
影响因子：
4.6
作者：
Grubbs, Joshua B.;Kraus, Shane W.;Gola, Mateusz
通讯作者：
Gola, Mateusz